Skip to main content

Does IVF Cause Cancer? What 25 Years of Registry Data Shows

IVF Education · September 1, 2026
ProIVF Medical Editorial Team · ProIVF Medical Advisory Board reviewed
does ivf cause cancerIVF cancer riskfertility treatment safetyIVF and ovarian cancerfertility drugs and breast cancer
Does IVF Cause Cancer? What 25 Years of Registry Data Shows

No — based on the largest cohort studies available, including national registry data covering hundreds of thousands of women followed for 10 to 25 years, current evidence shows no causal link between IVF and breast, ovarian, endometrial, or cervical cancer. The temporary hormone elevation during ovarian stimulation — estrogen rises to roughly 10–20x normal levels for only 10–14 days per cycle — has not been shown to increase cancer risk in any clinically meaningful way.

This is one of the most common fertility-treatment safety questions, and it makes intuitive sense to ask: IVF involves powerful hormone injections, repeated ultrasound monitoring, and sometimes surgery. But the single most important distinction is that many women undergoing IVF already have an infertility diagnosis that itself affects cancer risk — which is why national registry studies, not individual anecdotes, are the basis for judgment here. Data in this article comes from the CDC National ART Surveillance System, public ASRM guidance, large national registry cohort studies, and peer-reviewed medical literature.


Does IVF Cause Breast Cancer?

No. The largest studies consistently report no meaningful increase, and the most-studied cohort found breast cancer rates in IVF patients essentially identical to the general population.

In the table below, the standardized incidence ratio (SIR) compares cancer rates in the IVF group with the general population — near 1 means similar, above 1 means higher; the hazard ratio (HR) works the same way — an SIR of 1.01, for example, represents only a 1% difference from the general population.

StudyPopulationFollow-upResult
Dutch OMEGA cohort (NEJM, 2018)25,000+ women after IVFAverage 21 yearsSIR 1.01 — no increase
UK HFEA linkage study (2022)250,000+ women having fertility treatment1991–2010HR 1.02 (95% CI 0.99–1.05) — no significant increase
Nordic registry meta-analysis (2020)1.4 million women, 12 studies10–20 yearsNo overall increase in breast cancer incidence

The temporary rise in estrogen during stimulation — roughly 10–20x normal levels for 10–14 days per cycle — is a fundamentally different exposure from the decades of endogenous estrogen that drive most hormone-sensitive breast cancer risk. For a detailed review of this specific question, see our dedicated guide on IVF and breast cancer.


Does IVF Increase Ovarian Cancer Risk?

Not when the data are interpreted correctly — the key confounder is that infertility itself is associated with a higher risk of ovarian cancer, independent of any treatment. Women who never ovulate regularly, who have endometriosis, or who have never been pregnant carry an elevated baseline risk, so studies comparing IVF patients with the general population measure the combined effect of infertility plus treatment, not treatment alone.

When researchers correct for this, most large cohort studies — including the OMEGA cohort and Danish national registry data — find no significant increase in ovarian cancer risk attributable to IVF itself. Some meta-analyses report a small elevation that diminishes with longer follow-up, and there is an association with borderline ovarian tumors that requires further investigation but does not change clinical recommendations.


What About Endometrial, Cervical, and Thyroid Cancer?

The evidence is mixed but reassuring overall for endometrial cancer: IVF patients tend to be younger and are often diagnosed at early, treatable stages, and no large registry study has demonstrated a causal increase from IVF stimulation. For cervical cancer, no study has found an association with IVF — the relevant factor is regular cervical screening, which is standard care for all women.

Thyroid cancer is sometimes flagged because of repeated ultrasound exposure and hormonal changes, but large Scandinavian registry studies have not shown a causal link with IVF. Detected cases are usually explained by increased medical surveillance, and the same effect explains most short-term “increases” seen in the first year after treatment.


Why Do People Still Believe IVF Causes Cancer?

Because studies comparing IVF patients with the general population often show slightly higher cancer rates — but IVF patients are not representative of the general population:

  • Women with infertility have different baseline hormone profiles and ovulation patterns
  • They are more likely to have conditions like endometriosis and PCOS that carry their own risk profiles
  • They undergo far more medical surveillance, so cancers that would surface later are found earlier (detection bias)

When a study shows a small increase in cancer incidence in the first 1–2 years after IVF, the most plausible explanation is exactly this detection bias: women receiving IVF undergo more imaging, blood tests, and gynecological exams than the average woman of the same age. The apparent spike disappears with longer follow-up — the signature of surveillance, not harm.


What Do the CDC and ASRM Say About Cancer Risk?

The CDC’s ART surveillance system tracks IVF outcomes nationally but does not report cancer incidence. The American Society for Reproductive Medicine, ASRM, has reviewed the evidence on fertility drugs and cancer risk, and continues to recommend that patients discuss personal and family cancer history with their physician before treatment — a prudent, evidence-based approach.

“The available data do not demonstrate a causal association between ovulation induction or IVF and cancer.” — American Society for Reproductive Medicine (ASRM), evidence review on fertility drugs and cancer risk

For a technical review of fertility medication and cancer risk, see the peer-reviewed update indexed in the US National Library of Medicine. The US National Cancer Institute also provides plain-language guidance on hormones and cancer risk, and the CDC’s ART success rates page remains the definitive national source for treatment outcome data.


Who Should Take Extra Precautions Before IVF?

The overall evidence is reassuring, but certain groups deserve a more individualized risk assessment — the answer is not to skip IVF automatically, but to have an informed conversation with a reproductive endocrinologist who knows the full history.

GroupWhy extra caution mattersRecommended approach
BRCA1/BRCA2 mutation carriersElevated baseline breast and ovarian cancer riskGenetic counseling before treatment; discuss risk-reducing options with your specialist
Women with a personal history of hormone-sensitive cancerTreatment decisions are individualized; some protocols may be adjustedOncology and fertility team coordination (oncofertility consultation)
Women with a strong family history of breast or ovarian cancerMay warrant earlier or more frequent screeningDiscuss screening plan with your physician before starting IVF
Women with endometriosisBaseline elevated ovarian cancer risk is related to the disease, not treatmentEnsure endometriosis is managed; follow standard ovarian cancer screening advice

Many fertility centers now offer oncofertility programs that coordinate cancer and fertility care, including for patients who have completed cancer treatment and want to preserve fertility. Learn more about egg freezing for medical reasons and browse treatment centers in our hospital directory.


The Bottom Line on IVF and Cancer Risk

The evidence, taken as a whole, does not support the claim that IVF causes cancer. The largest and longest-running registry studies — covering hundreds of thousands of women across multiple countries — consistently find no clinically meaningful increase in breast, ovarian, endometrial, or cervical cancer risk attributable to IVF, and the small statistical signals in short-term data are best explained by the infertility confounder and the surveillance effect.

On current evidence, fear of cancer should not be a deciding factor against fertility treatment. What should guide the decision is the same thing that guides every medical decision: a thorough discussion of your personal risk profile with a qualified specialist, and treatment at a center that follows evidence-based protocols.


FAQ

Q: Does IVF cause breast cancer?

No. The largest cohort studies, including the Dutch OMEGA study with an average 21-year follow-up, report breast cancer rates in IVF patients essentially identical to the general population (SIR 1.01).

The short hormone exposure during stimulation — 10–14 days of elevated estrogen per cycle — has not been shown to meaningfully affect long-term risk — see our detailed IVF and breast cancer guide for the full data.

Q: Does IVF increase the risk of ovarian cancer?

Most large registry studies — including the Dutch OMEGA cohort (average 21-year follow-up) and Danish national registry data — find no significant increase attributable to IVF after adjusting for infertility itself, which is an independent risk factor. Some meta-analyses report a small elevation that diminishes with longer follow-up; women with BRCA mutations or a strong family history should discuss individualized screening with their specialist.

Q: Do fertility drugs cause cancer?

ASRM’s review of the evidence concludes that available data does not demonstrate a causal association between ovulation induction drugs or IVF and cancer. Estrogen rises only about 10–20x above normal for 10–14 days per stimulation cycle, which is not the pattern linked to hormone-driven cancers.

As with any medication, discuss risks with your physician if you have a personal or family history of cancer.

In studies that show any short-term statistical signal, it typically appears within the first 1–2 years after treatment and is attributed to detection bias, while longer follow-up of 10–25 years consistently shows no persistent increase. For example, the Nordic meta-analysis observed a slight elevation in the first year that disappeared entirely after five or more years of follow-up — the signature of surveillance bias rather than a true risk increase.

Q: Is IVF safe for cancer survivors?

For many cancer survivors, IVF and fertility preservation are safe and appropriate, but treatment must be coordinated between oncology and reproductive medicine teams. Timing, the hormone sensitivity of the original cancer, and preservation options all shape the plan; many centers run dedicated oncofertility programs, and registry cohorts such as OMEGA have followed women for an average of 21 years without a cancer signal.

Q: Should I do genetic testing before IVF if cancer runs in my family?

If you have a personal or strong family history of breast, ovarian, or other cancers, genetic counseling and testing — including BRCA1/BRCA2 screening — is recommended before starting IVF. This is not because IVF is dangerous; it is because your baseline risk profile may change how treatment and screening should be planned.


How to Plan Your IVF Journey With Confidence

  1. Get a baseline risk assessment. Discuss your personal and family history of cancer with a reproductive endocrinologist before starting treatment — this is standard care, not a reason to worry.
  2. Choose an evidence-based center. Work with a clinic that follows ASRM and CDC-recommended protocols and offers oncofertility coordination when needed; compare centers by location, success rates, and services in our hospital directory.
  3. Keep screening current. Continue regular breast and cervical screening as recommended for your age — IVF does not change that schedule.
  4. Ask direct questions. If a clinic tells you IVF causes cancer, that is a red flag; if they cannot explain the research, that is another one. You deserve a team that can walk you through the evidence.

For personalized guidance on choosing a clinic, you can also contact our team.


This article was written by the ProIVF Medical Editorial Team and reviewed by the ProIVF Medical Advisory Board. It is based on publicly available data from the CDC, ASRM, national registry cohort studies, and peer-reviewed literature to provide objective, accurate information for patients.

Medical Disclaimer: This article is for educational purposes only and does not replace professional medical advice. Always consult a qualified healthcare provider about your individual situation.

Last updated: September 1, 2026.

Ready to start your fertility journey?

Get a personalized plan from our medical advisors